ICUI Stock: Price, Earnings History and SEC Filings
ICU Medical, Inc. (ICUI) last traded at $163.78, down 2.89% on the latest session and up 2.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.01 against an analyst estimate of $1.49, a beat of 34.9%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ICUI earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $2.01 | $1.49 | +34.90% |
| Mar 2026 | May 7, 2026 | $1.55 | $1.33 | +16.54% |
| Dec 2025 | Feb 19, 2026 | $1.48 | $1.32 | +12.12% |
| Sep 2025 | Nov 6, 2025 | $1.66 | $1.13 | +46.90% |
ICUI beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How ICUI reacts to earnings
Across its last 8 earnings releases, ICUI moved 5.9% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | After close | +10.93% |
| 2026-05-07 | After close | +2.73% |
| 2026-02-19 | After close | +4.87% |
| 2025-11-06 | After close | +8.09% |
| 2025-08-07 | After close | -13.13% |
| 2025-05-08 | After close | -3.20% |
| 2025-02-27 | After close | -2.28% |
| 2024-11-12 | After close | -1.80% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ICUI financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.2B | $732000 | $92M | 0.0% | $0.03 |
| 2024 | $2.4B | -$118M | $125M | -4.9% | $-4.83 |
| 2023 | $2.3B | -$30M | $82M | -1.3% | $-1.23 |
| 2022 | $2.3B | -$74M | -$152M | -3.3% | $-3.11 |
| 2021 | $1.3B | $103M | $199M | 7.8% | $4.74 |
| 2020 | $1.3B | $87M | $131M | 6.8% | $4.02 |
| 2019 | $1.3B | $101M | $5M | 8.0% | $4.69 |
| 2018 | $1.4B | $29M | $67M | 2.1% | $1.33 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ICUI
- 10-Q · Aug 6, 2026
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- 8-K · May 18, 2026Bylaw change, Shareholder vote, Financial statements and exhibits
- 10-Q · May 7, 2026
- 8-K · May 7, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 2, 2026
- 8-K · Feb 20, 2026Officer or director change, Financial statements and exhibits
- 10-K · Feb 19, 2026
- 8-K · Feb 19, 2026Results of operations, Financial statements and exhibits
- 10-Q · Nov 6, 2025
Insider filing activity
ICUI insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ICUI news
- 3 small-cap stocks we find riskyOct 23, 2026 · finance.yahoo.com
- ICU Medical Announces Time of Third Quarter 2026 Earnings Conference CallOct 22, 2026 · finance.yahoo.com
About ICU Medical, Inc.
ICU Medical, Inc. (ICUI) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.